Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs2922994
rs2922994 		0.710 GeneticVariation BEFREE Here we perform a two-stage GWAS of 1,281 MZL cases and 7,127 controls of European ancestry and identify two independent loci near BTNL2 (rs9461741, P=3.95 × 10(-15)) and HLA-B (rs2922994, P=2.43 × 10(-9)) in the HLA region significantly associated with MZL risk. 25569183

2015
dbSNP: rs2922994
rs2922994 		G 0.710 GeneticVariation GWASCAT Here we perform a two-stage GWAS of 1,281 MZL cases and 7,127 controls of European ancestry and identify two independent loci near BTNL2 (rs9461741, P=3.95 × 10(-15)) and HLA-B (rs2922994, P=2.43 × 10(-9)) in the HLA region significantly associated with MZL risk. 25569183

2015
dbSNP: rs9461741
rs9461741
BTNL2 ; TSBP1-AS1
C 0.710 GeneticVariation GWASCAT Here we perform a two-stage GWAS of 1,281 MZL cases and 7,127 controls of European ancestry and identify two independent loci near BTNL2 (rs9461741, P=3.95 × 10(-15)) and HLA-B (rs2922994, P=2.43 × 10(-9)) in the HLA region significantly associated with MZL risk. 25569183

2015
dbSNP: rs9461741
rs9461741
BTNL2 ; TSBP1-AS1
0.710 GeneticVariation BEFREE Here we perform a two-stage GWAS of 1,281 MZL cases and 7,127 controls of European ancestry and identify two independent loci near BTNL2 (rs9461741, P=3.95 × 10(-15)) and HLA-B (rs2922994, P=2.43 × 10(-9)) in the HLA region significantly associated with MZL risk. 25569183

2015
dbSNP: rs1107345
rs1107345
IL2RA
0.700 GeneticVariation GWASCAT Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes. 31407831

2019
dbSNP: rs1250550
rs1250550
ZMIZ1
0.700 GeneticVariation GWASCAT Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes. 31407831

2019
dbSNP: rs1323292
rs1323292
LOC105371664
0.700 GeneticVariation GWASCAT Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes. 31407831

2019
dbSNP: rs1364229
rs1364229 		A 0.700 GeneticVariation GWASCAT Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes. 31407831

2019
dbSNP: rs1439112
rs1439112
MGAT5
0.700 GeneticVariation GWASCAT Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes. 31407831

2019
dbSNP: rs1444766
rs1444766
KALRN
G 0.700 GeneticVariation GWASCAT Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes. 31407831

2019
dbSNP: rs16947122
rs16947122
FBXW8
C 0.700 GeneticVariation GWASCAT Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes. 31407831

2019
dbSNP: rs2425752
rs2425752
NCOA5
0.700 GeneticVariation GWASCAT Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes. 31407831

2019
dbSNP: rs2777899
rs2777899
VMP1
0.700 GeneticVariation GWASCAT Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes. 31407831

2019
dbSNP: rs2941509
rs2941509
IKZF3
T 0.700 GeneticVariation GWASCAT Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes. 31407831

2019
dbSNP: rs6062314
rs6062314
ZBTB46
0.700 GeneticVariation GWASCAT Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes. 31407831

2019
dbSNP: rs7382170
rs7382170 		0.700 GeneticVariation GWASCAT Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes. 31407831

2019
dbSNP: rs8021741
rs8021741
LOC107984652
0.700 GeneticVariation GWASCAT Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes. 31407831

2019
dbSNP: rs387907272
rs387907272
MYD88
0.060 GeneticVariation BEFREE The diagnosis of Waldenström Macroglobulinaemia (WM)/lymphoplasmacytic lymphoma (LPL) remains one of exclusion because other B-cell lymphoproliferative disorders (B-LPD), such as marginal zone lymphoma (MZL), can fulfil similar criteria, including MYD88 L265P mutation. 30198568

2019
dbSNP: rs387907272
rs387907272
MYD88
0.060 GeneticVariation BEFREE MYD88 L265P was found in 49/51 (96%) LPL cases and in 1/13 (7·6%) MZL (splenic type), whereas all CLL samples remained negative. 25819228

2015
dbSNP: rs387907272
rs387907272
MYD88
0.060 GeneticVariation BEFREE MYD88 (L265P) somatic mutation in marginal zone B-cell lymphoma. 25723115

2015
dbSNP: rs387907272
rs387907272
MYD88
0.060 GeneticVariation BEFREE Thus, pyrosequencing for the MYD88 L265P mutation demonstrates a high clinical sensitivity and specificity to distinguish LPL from MZL and CLL. 26230596

2015
dbSNP: rs387907272
rs387907272
MYD88
0.060 GeneticVariation BEFREE The most distinguishing features of LPL with respect to MZL were focal paratrabecular involvement (P < .001), the presence of lymphoplasmacytoid cells (P < .001) and Dutcher bodies (P < .001), increased numbers of mast cells (P < .001), and the MYD88 L265P mutation (P < .001). 25972321

2015
dbSNP: rs387907272
rs387907272
MYD88
0.060 GeneticVariation BEFREE IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas. 22944768

2013
dbSNP: rs344550
rs344550
C3
0.010 GeneticVariation BEFREE Additionally, SNPs (C2 rs497309, A>C and C3 rs344550, G>C) in two complement genes were positively associated with marginal zone lymphoma (MZL) and C1QG was associated with CLL/SLL, but these results were based on a limited number of cases. 22170086

2012
dbSNP: rs497309
rs497309
C2 ; CYP21A2
0.010 GeneticVariation BEFREE Additionally, SNPs (C2 rs497309, A>C and C3 rs344550, G>C) in two complement genes were positively associated with marginal zone lymphoma (MZL) and C1QG was associated with CLL/SLL, but these results were based on a limited number of cases. 22170086

2012